المؤلفون: Miriam Koopman, Gerrit Jan Veldhuis, Cornelis J. A. Punt, Steven Teerenstra, Daan ten Bokkel Huinink, Veerle A. Derleyn, Erik W. Muller, Linda Mol, Lieke H.J. Simkens

المساهمون: Graduate School, Oncology

المصدر: European journal of cancer (Oxford, England, 47(17), 2560-2567. Elsevier Limited
European Journal of Cancer, 47, 17, pp. 2560-7
European Journal of Cancer, 47, 2560-7

مصطلحات موضوعية: Oncology, Male, Cancer Research, Multivariate analysis, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Deoxycytidine, Targeted therapy, Body Mass Index, Antineoplastic Combined Chemotherapy Protocols, Molecular Targeted Therapy, Aged, 80 and over, Prognostic factor, Middle Aged, Bevacizumab, Oxaliplatin, Treatment Outcome, Chemotherapy, Adjuvant, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Quality of nursing and allied health care [NCEBP 6], Irinotecan, Advanced colorectal cancer, Translational research [ONCOL 3], Internal medicine, medicine, Chemotherapy, Humans, Obesity, Capecitabine, Aged, Retrospective Studies, business.industry, medicine.disease, Survival Analysis, Evaluation of complex medical interventions [NCEBP 2], Camptothecin, business, Body mass index

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c4ae99dfcbf1f306dc6aa5f683e041

المؤلفون: Doreen Dobritzsch, Rutger Meinsma, Marion Kiechle, Adri Mul, Veronika Schmid, Veerle A. Derleyn, Ed Maartense, Marie-Christine Etienne-Grimaldi, Marcel M.A.M. Mannens, André B.P. van Kuilenburg, Heinz-Josef Klümpen, Raymon Vijzelaar, J. G. Maring, Raoul C.M. Hennekam, Eva Gross, Gérard Milano, Judith Meijer

المساهمون: AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Laboratory Genetic Metabolic Diseases, ANS - Amsterdam Neuroscience, APH - Amsterdam Public Health, Paediatrics, ACS - Amsterdam Cardiovascular Sciences, ARD - Amsterdam Reproduction and Development, Human Genetics, Oncology, Faculteit der Geneeskunde

المصدر: Human genetics, 128(5), 529-538. Springer Verlag
Human Genetics, 128(5), 529-538. Springer Verlag
Human Genetics

مصطلحات موضوعية: Adult, Male, Silent mutation, Antimetabolites, Antineoplastic, RNA Splicing, Population, Mutation, Missense, Biology, Polymerase Chain Reaction, Exon, Dihydropyrimidine dehydrogenase, Genetics, Humans, Genetics(clinical), RNA, Messenger, education, Dihydrouracil Dehydrogenase (NADP), Genetics (clinical), Aged, Sequence Deletion, Original Investigation, Gene Rearrangement, Comparative Genomic Hybridization, education.field_of_study, Polymorphism, Genetic, Sequence Analysis, DNA, Gene rearrangement, Middle Aged, Molecular biology, Introns, Mutation (genetic algorithm), RNA splicing, Female, DPYD, Fluorouracil

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a149aca74d5cd44a7127c6be9a4b74
https://hdl.handle.net/11245/1.341830

المؤلفون: Hans J Braun, Olaf Loosveld, Albert J. ten Tije, Adelheid M. E. van der Torren, Cornelis J. A. Punt, Jacobus J.M. van der Hoeven, Miriam Koopman, Aafk E. H. Honkoop, Frans L. G. Erdkamp, Jaap Wals, Rob L. H. Jansen, Anne May, Peter Nieboer, Veerle A. Derleyn, Lieke H.J. Simkens, Annemieke Cats, Felix E de Jongh, Zoran Erjavec, Linda Mol, Jolien Tol, Geert-Jan Creemers, Janny G. Haasjes, Harm van Tinteren

المساهمون: Graduate School, CCA -Cancer Center Amsterdam, Oncology, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Lancet, 385(9980), 1843-1852. Elsevier Limited
The Lancet, 385(9980), 1843. Elsevier Limited
Lancet, 385(9980), 1843-1852. Elsevier Science
The Lancet (London), 385, 9980, pp. 1843-52
The Lancet (London), 385, 1843-52

مصطلحات موضوعية: Oncology, Male, Organoplatinum Compounds, Colorectal cancer, Clinical Trial, Phase III, Kaplan-Meier Estimate, Deoxycytidine, law.invention, Randomized controlled trial, law, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, 80 and over, Medicine, Neoplasm Metastasis, Non-U.S. Gov't, Humanized, Aged, 80 and over, Research Support, Non-U.S. Gov't, General Medicine, Middle Aged, Clinical Trial, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oxaliplatin, Bevacizumab, Multicenter Study, Treatment Outcome, Randomized Controlled Trial, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Research Support, Antibodies, Capecitabine, Phase III, Internal medicine, Journal Article, Humans, Aged, Neoplasm Staging, Intention-to-treat analysis, Performance status, business.industry, medicine.disease, Surgery, Regimen, business

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d341513745af9240b05212b8aba4b77
https://hdl.handle.net/1874/337788

المؤلفون: Marion Kiechle, Marie-christine Etienne-grimaldi, Heinz-josef Klümpen, Jan Gerard Maring, Veerle A. Derleyn, Gérard Milano, Raymon Vijzelaar, Eva Gross, V. Schmid, M. Kiechle, E. Gross, D. Dobritzsch, R. C. M. Hennekam

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/f3/84/Hum_Genet_2010_Nov_29_128(5)_529-538.tar.gz

وصف الملف: application/zip

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.351.403

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.351.403